Filing Details
- Accession Number:
- 0001209191-19-025373
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-19 16:13:47
- Reporting Period:
- 2019-04-17
- Accepted Time:
- 2019-04-19 16:13:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1586893 | Scott J Wolchko | C/O Fate Therapeutics, Inc.; 3535 General Atomics Court #200 San Diego CA 92121 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-04-17 | 1,092 | $1.63 | 375,973 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-17 | 1,092 | $16.11 | 374,881 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-04-17 | 7,449 | $1.63 | 382,330 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-17 | 7,449 | $16.18 | 374,881 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-04-18 | 6,843 | $1.63 | 381,724 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-18 | 6,843 | $16.01 | 374,881 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-04-18 | 4,616 | $1.63 | 379,497 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-18 | 4,616 | $16.02 | 374,881 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-04-17 | 1,092 | $0.00 | 1,092 | $1.63 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-04-17 | 7,449 | $0.00 | 7,449 | $1.63 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-04-18 | 6,843 | $0.00 | 6,843 | $1.63 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-04-18 | 4,616 | $0.00 | 4,616 | $1.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,843 | 2022-02-08 | No | 4 | M | Direct | |
| 18,951 | 2022-02-08 | No | 4 | M | Direct | |
| 0 | 2022-02-08 | No | 4 | M | Direct | |
| 14,335 | 2022-02-08 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018.
- Represents the weighted average sale price of the shares sold ranging from $16.00 to $16.73 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $16.00 to $16.84 per share. The Reporting person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $16.00 to $16.04 per share. The Reporting person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- The shares subject to this option became fully vested and exercisable on May 30, 2015.
- Not applicable.
- The shares subject to this option became fully vested and exercisable on October 4, 2015.
Billionaire Hedge Funds
